CTRVP
HEPION PHARM INC PFD by Hepion Pharmaceuticals, Inc. (CTRVP)
$00
0
About HEPION PHARM INC PFD by Hepion Pharmaceuticals, Inc. (CTRVP)
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
--
52 Week Low
--
Market cap
--
Dividend yield
--
Volume
2
Avg. volume
--
P/E ratio
--
HEPION PHARM INC PFD by Hepion Pharmaceuticals, Inc. News
0
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
--
52 Week Low
--
Market cap
--
Dividend yield
--
Volume
2
Avg. volume
--
P/E ratio
--